2
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A Computer-Based Method to Rapidly Analyze Tumor Cell Lysis In. Vivo

, , , &
Pages 83-106 | Published online: 28 Sep 2008

References

  • Arosety J., Lincoln T., Shapiro N., Boccia G. “Tumor Growth and Chemotherapy: Mathematical Methods, Computer Simulations, and Experimental Foundations. Math. Biosci. 1973; 17: 243
  • Duchting W. Modeling Cancer Problems and its Progress, Computer Modeling of Complex Biological Systems, S. S. Iyengar. CRC Press, Boca Ration, Florida 1984; 56
  • Ehrke M. J., Ryoyama K., Cohen S. A. “Cellular Basis for Adriamycin-Induced Augmentation of Cell-Mediated Cytotoxicity in Culture,”. Can. Res. 1984; 44: 2497
  • Law A. M., Kelton W. D. “Simulation Modeling and Analysis,”. McGraw-Hill Book Co., New York 1982
  • Look A. T., Schriber T. J., Nawrocki J. F., Murphy W. H. “Computer Simulation of the Cellular Immune Response to Malignant Lymphoid Cells: Logic of Approach. Model Design and Laboratory Verification,” Immunology 1981; 43: 679
  • Lukasewycz O. A., Martinez D., Murphy W. H. “Immune Mechanisms in Leukemia: Evaluation of Immunocompetent Cell Populations,”. J. Immunol. 1975; 114: 1491
  • Lukasewycz O. A., Duffey P. S., Murphy W. H. “Immune Mechanisms in Leukemia: Protective Capacity of the Major Lymphoid Cell Compartments,”. J. Immunol. 1976; 116: 976
  • Martinez D., Lukasewycz O. A., Murphy W. H. “Immune Mechanisms in Leukemia: Suppression of Cellular Immunity by Drugs and X-irradiation,”. J. Immunol. 1975; 115: 724
  • Mauer A. M., Evert Jr., C.F., Lampkin B. C., McWilliams N. B. Cell Kinetics in Human Lymphoblastic Leukemia: Computer Simulation with Discrete Modeling Techniques. Blood 1973; 41: 141
  • Murphy W. H., Look A. T., Truax T. D., Selwa J. F., Nawrocki J. F., Schriber T. J. “Analysis of the Immune Response to Malignant Cells by Computer Simulation,”. Proc. 6th Annual Sympos. Computer Applicat. in Med. Care (Oct.-Nov. 1982; 957
  • Nawrocki J. F., Look A. T., Selwa J. F., Haggis J. R., Murphy W. H. “Distribution and Lysis of Weakly and Strongly Immunogenic Malignant Lymphoid Cells in Normal and Immune Mice: Effects of Prior Exposure to Heat and X-irradiation,”. J. Natl. Cancer Inst. 1984; 72: 1085
  • Rowland M. “Physiologic Pharmacokinetic Models: Relevance, Experience and Future Trends,”. Drug Metab. Rev. 1984; 15: 55
  • Schriber T. J. Simulation Using GPSS, 1st ed. John Wiley and Sons, NY 1984
  • Shackney S. E. “A Computer Model for Tumor Growth and Chemotherapy, and its Application to L1210 Leukemia Treated with Cytosine Arabinoside (NSC-63878),” Cancer Chem. Repts. 54, 399, 1970
  • Sheiner L. B., Grasela T. H. “Experience with NONMEM: Analysis of Routine Phenytoin Clinical Pharmacokinetic Data,”. Drug Metab. Rev. 1984; 15: 293
  • Stevens S. K., Weissman I. L., Butcher E. C. “Differences in the Migration of B and T Lymphocytes: Organ-Selective Localization. in Vivo 1982; 128: 844, and the role of Lymphocyte-Endothelial Cell Recognition,” J. Immunol..
  • Talmadge J. E., Oldham R. K., Fidler I. J. “Practical Considerations for the Establishment of a Screening Procedure for the Assessment of Biological Response Modifiers,”. J. Biol. Response Mod. 1984; 3: 88
  • Valeriote F., Medoff G., Dieckman J. “Potentiation of Cytotoxicity of Anticancer Agents by Several Different Polyene Antibiotics,”. J. Natl. Cancer Inst. 1984; 74: 435
  • Wang B. S., Lumanglas A. L., Ruszala-Mallon V. M., Durr F. E. “Activation of Tumor-Cytostatic Macrophages with the Antitumor Agent 9,10-anthracene-dicarboxaldehyde BIS [(4,5-dihydro-1H-imidazole-2-yl)] dihydrochloride (Bisantrene),”. Can. Res. 1984; 44: 2363

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.